ABCL · Insider Trading
AbCellera Biologics Inc. Common Shares
Every open-market purchase and sale reported by ABCL officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Michael R Hayden | Director | Buy | +53,613 | +$570.44K |
| 2026-08-18 | John S. Montalbano | Director | Buy | +10,000 | +$110.30K |
| 2026-08-14 | Michael R Hayden | Director | Buy | +46,387 | +$481.03K |
| 2026-08-14 | Andrew Booth | Chief Financial Officer | Buy | +37,200 | +$383.90K |
| 2026-08-13 | Michael R Hayden | Director | G | −50,000 | — |
| 2026-07-06 | Lynn Seely | Director | A | +152,207 deriv. | — |
| 2026-07-06 | Victor Sandor | Director | A | +152,207 deriv. | — |
| 2026-06-12 | Michael R Hayden | Director | A | +111,701 deriv. | — |
| 2026-06-12 | Stephen Quake | Director | A | +111,701 deriv. | — |
| 2026-06-12 | John S. Montalbano | Director | A | +111,701 deriv. | — |
| 2026-06-03 | Andrew Booth | Chief Financial Officer | M | +250,000 | +$47.50K |
| 2026-05-18 | John S. Montalbano | Director | Buy | +20,000 | +$95.40K |
| 2026-03-02 | Thermopylae Holdings Ltd. | 10%+ Owner | Buy | +38,000 | +$130.72K |
| 2026-02-27 | Thermopylae Holdings Ltd. | 10%+ Owner | Buy | +177,457 | +$580.28K |
| 2026-02-27 | Andrew Booth | Chief Financial Officer | Buy | +42,600 | +$145.69K |
| 2026-01-05 | Veronique Lecault | Chief Technology Officer | A | +539,265 deriv. | — |
| 2026-01-05 | Andrew Booth | Chief Financial Officer | A | +808,898 deriv. | — |
| 2026-01-05 | Tryn Stimart | Chief Legal Officer | A | +539,265 deriv. | — |
| 2026-01-05 | Carl L. G. Hansen | Chief Executive Officer | A | +2,106,505 deriv. | — |
| 2025-12-19 | Stephen Quake | Director | A | +194,932 deriv. | — |
| 2025-12-19 | Thermopylae Holdings Ltd. | 10%+ Owner | G | −225,000 | — |
| 2025-11-26 | John S. Montalbano | Director | Buy | +50,000 | +$178.46K |
| 2025-07-01 | Michael R Hayden | Director | A | +238,864 deriv. | — |
| 2025-06-16 | John S. Montalbano | Director | A | +238,864 deriv. | — |
| 2025-06-16 | Andrew Lo | Director | A | +238,864 deriv. | — |
| 2025-03-11 | Thermopylae Holdings Ltd. | 10%+ Owner | Buy | +343,631 | +$742.24K |
| 2025-03-10 | John S. Montalbano | Director | Buy | +25,000 | +$57.50K |
| 2025-03-07 | John S. Montalbano | Director | Buy | +60,000 | +$140.57K |
| 2025-01-03 | Andrew Booth | Chief Financial Officer | A | +1,352,054 deriv. | — |
| 2025-01-03 | Tryn Stimart | Chief Legal Officer | A | +832,033 deriv. | — |
| 2025-01-03 | Veronique Lecault | Chief Operating Officer | A | +832,033 deriv. | — |
| 2025-01-03 | Carl L. G. Hansen | Chief Executive Officer | A | +2,730,109 deriv. | — |
| 2024-12-05 | Thermopylae Holdings Ltd. | 10%+ Owner | G | −286,000 | — |
| 2024-11-26 | Carl L. G. Hansen | Chief Executive Officer | M | +56,125 | +$151.54K |
| 2024-09-24 | Carl L. G. Hansen | Chief Executive Officer | M | +56,125 | +$151.54K |
| 2024-08-29 | Thermopylae Holdings Ltd. | 10%+ Owner | Buy | +283,516 | +$739.98K |
| 2024-06-24 | John S. Montalbano | Director | A | +163,934 deriv. | — |
| 2024-06-24 | Michael R Hayden | Director | A | +163,934 deriv. | — |
| 2024-06-24 | Andrew Lo | Director | A | +163,934 deriv. | — |
| 2024-06-24 | Veronique Lecault | Chief Operating Officer | M | +83,334 | +$15.67K |
| 2024-06-03 | Carl L. G. Hansen | Chief Executive Officer | M | +56,125 | +$151.54K |
| 2024-02-27 | Carl L. G. Hansen | Chief Executive Officer | M | +56,125 | +$151.54K |
| 2024-01-16 | Tryn Stimart | Chief Legal Officer | A | +616,333 deriv. | — |
| 2024-01-16 | Veronique Lecault | Chief Operating Officer | A | +770,416 deriv. | — |
| 2024-01-16 | Andrew Booth | Chief Financial Officer | A | +770,416 deriv. | — |
| 2024-01-16 | Carl L. G. Hansen | Chief Executive Officer | A | +2,095,532 deriv. | — |
| 2023-12-19 | Thermopylae Holdings Ltd. | 10%+ Owner | G | −210,000 | — |
| 2023-11-27 | Carl L. G. Hansen | Chief Executive Officer | M | +56,125 | +$151.54K |
| 2023-11-08 | John S. Montalbano | Director | Buy | +30,000 | +$137.40K |
| 2023-09-26 | Michael R Hayden | Director | Buy | +20,000 | +$98.20K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Carl L. G. Hansen | Chief Executive Officer | 56,984,009 | $697.48M |
| Thermopylae Holdings Ltd. | 10%+ Owner | 56,134,097 | $687.08M |
| Veronique Lecault | Chief Technology Officer | 2,397,086 | $29.34M |
| Michael R Hayden | Director | 1,373,397 | $16.81M |
| Andrew Booth | Chief Financial Officer | 613,759 | $7.51M |
| John S. Montalbano | Director | 256,000 | $3.13M |
| Andrew Lo | Director | 86,938 | $1.06M |
| Tryn Stimart | Chief Legal Officer | 500 | $6.12K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ABCL quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.